LOS ANGELES, CA–(Marketwire – December 2, 2010) – MMRGlobal, Inc. (OTCBB: MMRF) (MMR) and Texas-based MMX Holdings, LLC, today announced integration of MMRPro into the MMX dashboard-based financial and operating management tool for ambulatory surgical centers (ASCs) (www.managemyasc.com). The Company’s MMRPro electronic document management system for healthcare professionals will be featured on the Manage My ASC dashboard and as a result marketed to thousands of surgery centers located throughout the United States.

The Manage My ASC system was specifically designed to increase productivity and profitability in surgery centers which should help drive sales of MMRPro. As part of the transaction, MMRGlobal became a minority equity holder of MMX Holdings and MMX acquired 750,000 warrants in MMRF at terms and conditions that include purchase prices up to 18 cents per share.

“This transaction demonstrates how MMR can use its equity to create relationships that will allow us to expand our Electronic Medical Record product and service offerings in a coordinated effort to deliver meaningful use to healthcare professionals,” said Robert H. Lorsch, MMRGlobal Chairman and CEO. “It is the most recent example of the Company’s plan to deliver a suite of health information products and services through strategic alliances, partnerships and acquisitions. In addition to MMRPro and the MyMedicalRecords Personal Health Record, these could include one or more Electronic Medical Record products that run on different platforms including the iPad.”

“The opportunity for MMR to sell its services to a targeted market such as surgery centers offers a unique revenue opportunity for the Company,” Lorsch added. “We will continue to explore similar relationships in radiology, hospital systems, veterinary medicine and other specialties.” Lorsch is already a major shareholder and board member of Dancing Paws, a manufacturer of veterinary vitamins, supplements and treats including green bones.

According to John R. Seitz, CEO of Manage My ASC, “The relationship with MMR is one example of how our Manage My ASC Dashboard can streamline the operations of a surgery center and make it operate more effectively and profitably. Surgery centers receive a lot of different types of documents from referring physicians and MMRPro integrated with the dashboard can help manage and consolidate all patient records from any EMR or plain paper-based system employed by the center.”

The relationship with MMX evolved as a result of MMR’s installation of MMRPro at the Spalding Surgical Center of Beverly Hills. Installing MMRPro at Spalding exposed the system to more than 20 physician groups operating at the center at any given time. The Company quickly realized that selling through surgery centers represented a cost-effective way to market MMRPro to physicians. The Manage My ASC Dashboard creates the opportunity to provide a hands-on experience to tens of thousands of physicians referring to or operating at surgery centers when compared to the cost of selling offices of individual healthcare professionals one by one. 

“With over 6,000 in the U.S., ambulatory surgery centers are one of the fastest-growing elements of medical care across the country. Surgery centers will generally support 20 to 30 doctors, each with a patient list of 2,000 or more. The surgery center environment presents a distinctive market for MMR to offer its MMRPro solutions to significant physician populations. We are pleased that MMR is joining other well-known entities, including Kerlan-Jobe, one of the world’s foremost sports medicine destinations,” Seitz added.

MMRPro allows physicians working out of a surgery center to have electronic access to patient documentation, regardless of the system currently used in their offices, and enables the ASC to receive medical records securely from all their treating physicians. The system also cost-effectively digitizes and securely uploads medical records and makes them available to patients in real time while generating stimulus money to referring physicians.

The MMRPro solution is supported by Kodak’s Scan Station 520MDP. Surgery centers may also participate in the MMRPro Stimulus Program. As a result, a surgery center can participate in potentially hundreds of thousands of dollars of recurring upgrade revenue annually coming from the thousands of patients treated at the surgery centers at any given time when contrasted to the number of patients in a typical MMRPro group practice installation. The MMRPro Stimulus Program provides funds to physicians, hospitals and alternative care facilities for patient upgrades to a full-featured MyMedicalRecords Personal Health Record in addition to stimulus monies that may be provided by the federal government.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

About Manage My ASC

Manage My ASC combines timely and focused management reporting, backed-up by our team of industry experts, to deliver management solutions to ASC owners and operators. Our easy to understand on-line dashboard is a powerful management tool and serves as a central reference point for you to view and track your ASC’s activities. Plus, your dashboard is the main meeting point for you and our experts who are there to help you interpret results and take action.

The Manage My ASC solution works for any ASC, regardless of size or geographic location. Manage My ASC customers receive periodic reviews of operation performance, including assessments based on our comprehensive benchmarking database, that lead to specific recommendations to capture improvement opportunities. www.managemyasc.com

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management’s expectations, beliefs, intentions, estimates or projections, constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “help,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. . Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company’s products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company’s marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Click here to see all recent news from this company

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Dec. 2, 2010) – Premier Diagnostic Health Services Inc. (CNSX:PDH) (“PDH”) announces Denis Tusar, CEO – China Operations for PDH, is departing to China, on Saturday, December 4, 2010 to meet with the on-the-ground China Development Team. 

The Team will work under his supervision to negotiate and finalize four to six contracts with qualifying hospitals for the establishment of Centers for Advanced Diagnostics that will utilize PET-CT technology for detection and evaluation of cancer. 

Working from the model established by PDH in collaboration with the No. 3 Armed Police Hospital in Beijing where the first Center has been operating an MRI scanner for three months, PDH will provide and own the PET-CT scanners. The Centers will be operated in collaboration with the hospitals over a 10 – 12 year period with positive revenues expected to be generated from the outset.

PDH is retaining the services of a senior executive from a major Chinese Trading Company to head up the China Development Team. 

About Premier Diagnostic Health Services Inc. (CNSX:PDH)

As leaders in advanced health and education with the international medical community, PDH is rolling out its global strategy of establishing a network of Centres for Advanced Diagnostics in Canada and China. By utilizing MRI and PET-CT, the most advanced medical diagnostic imaging technology available and the production of FDG, the radiopharmaceutical tracer used in oncology PET procedures; PDH is uniquely positioned to deliver continued innovation, growth and profitability.

PHILADELPHIA, PA–(Marketwire – December 2, 2010) – Sullivan, Cotter and Associates, Inc., a health care compensation and human resource management consulting firm, has announced the opening of its newest business location in Philadelphia. With offices in the major markets of Atlanta, Boston, Chicago, Detroit, New York, Parsippany, San Francisco and Westport, Philadelphia was a natural additional market for the nationally regarded compensation consulting firm. The new location is at 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.

“We are enthusiastic about our continued growth in the east coast. Our presence in Philadelphia will allow us to meet our commitment to superior client service and accessibility for local health care organizations,” notes SullivanCotter Managing Director, Chris Terranova. “SullivanCotter’s compensation strategies ensure that organizations are in compliance with a myriad of regulatory matters while also being sensitive to the concerns of their boards,” Terranova adds.

Bruce Greenblatt will open the Philadelphia office as a Principal of the Firm. Greenblatt has more than 14 years of consulting experience with particular expertise in executive compensation in the health care industry, as well as the consumer products, manufacturing and communications industries. He has advised the senior management and boards of nonprofit, publicly-traded and private companies on compensation strategy as well as in the design and implementation of executive incentive and other programs.

Sullivan, Cotter and Associates, Inc. specializes in the assessment and development of total compensation and reward programs for executives and physicians in the health care industry. Since 1992, SullivanCotter has worked closely with health care organization executives, boards and compensation committees to devise innovative compensation solutions that attract and retain leadership talent while satisfying not-for-profit missions and regulatory requirements. A leader in independent consulting, benchmarking, trends and analyses, SullivanCotter has also developed the most widely recognized physician and executive compensation surveys in the United States. For more information, visit www.sullivancotter.com or call 888-739-7039 toll-free. In Philadelphia, please call 484-534-2922.

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Dec. 2, 2010) – ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) (the “Company”) announces that new tests have shown that T³6^® Antiseptic Hand Sanitizer is completely effective against two types of new “superbugs” within 15 seconds. The testing was conducted at BioScience Laboratories in Bozeman, MT against antibiotic-resistant strains of E. coli and Klebsiella. These strains have taken genes from other bacteria that have developed the ability to digest nearly all antibiotics, including penicillin-like antibiotics that possess broad spectrum antibacterial properties and are typically used as a last resort. Such genetic “swapping” is common among bacteria and is a major cause of antibiotic resistance.

Dr. Terrance Owen, President & CEO comments, “T³6^® Antiseptic Hand Sanitizer works in a completely different way than antibiotics. It kills infectious organisms by disrupting their cell walls so the presence of antibiotic-digesting enzymes does not stop it from working. Since these infections are so dangerous, it is important to prevent them from happening in the first place. Proper hygiene, including the use the of hand sanitizers and disinfectants such as T³6^® Antiseptic Hand Sanitizer and T³6^® Disinfectant, is a very important step in preventing the spread of potentially incurable diseases.”

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T³6^® technology. The Company trades on the TSX Venture Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning products. The Company was also selected as one of the TSX Venture 50 companies in the Technology and Life Sciences sector for 2010.

Terrance G. Owen, Ph.D., MBA
President & CEO
ALDA Pharmaceuticals Corp.
www.aldacorp.com

The Units, common shares, warrants and the common shares issuable upon exercise of the warrants have not been registered under the United States Securities Act of 1933 (the “Act”) and may not be offered or sold absent registration under the Act or an applicable exemption from the registration requirements thereof. This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or an exemption therefrom.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA’s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as “outlook”, “will”, “could”, “would”, “might”, “remains”, “to be”, “plans”, “believes”, “may”, “expects”, “intends”, “anticipates”, “estimate”, “future”, “plan”, “positioned”, “potential”, “project”, “remain”, “scheduled”, “set to”, “subject to”, “upcoming”, and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

RYE BROOK, NY–(Marketwire – December 2, 2010) – CBLPath today announced that it is now officially part of Sonic Healthcare Limited’s federation of laboratories.

CBLPath will work closely with Sonic’s clinical laboratory divisions to cross sell services to their respective referrer bases. Significant revenue synergies are expected to be realized from the cross sell opportunities in FY2012 and following years. In addition, there are a number of cost synergies which Sonic can offer CBLPath, particularly in the areas of logistics, purchasing and billing.

CBLPath has been operating under the direction of the Office of the CEO comprised of David W. Bryant, President and Chairman of the Board; Dr. Carlos D. Urmacher, Chief Medical Officer; and Joe Sinicropi, Chief Operating Officer. At this time, the Office of the CEO will be disbanded and Mr. Bryant will assume the role of CBLPath’s Chief Executive Officer. Dr. Urmacher will continue in his role as Chief Medical Officer and Mr. Sinicropi in his role as Chief Operating Officer.

The company will continue to operate under the CBLPath name.

About CBLPath
CBLPath is a national specialty lab offering a full convergence of anatomic, molecular and digital pathology services. The company provides a one-stop solution for comprehensive sub-specialized diagnostics, and timely, accurate, patient-centered disease management guidance. Through its Best Practice™ Partnership Program, CBLPath partners with pathologists to help them grow their practices, while giving them the ability to stay independent and “keep medicine local.” The company also provides sub-specialty physicians access to comprehensive, high-quality testing in their local market. Founded in 1988, CBLPath established a reputation for providing timely, highly accurate diagnoses along with extraordinary customer service and a true patient-centered commitment. For more about the company, please visit www.CBLPath.com.

About Sonic Healthcare Limited
Sonic Healthcare is one of the world’s largest medical diagnostics companies, providing laboratory and radiology services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare Limited is the parent company of the many operating companies around the world comprising the Sonic Healthcare group. It is a public company, listed on the Australian Securities Exchange (ASX), where it is classified as one of Australia’s “Top 100” companies. Sonic Healthcare has its head office at Macquarie Park in Sydney, Australia, in the same building as the main Douglass Hanly Moir Pathology laboratory. In the medical arena, their success is based on the fact that Sonic Healthcare companies are recognized as quality diagnostic practices that have remained true to the ethical principles of the medical profession. For more about the company, please visit www.sonichealthcare.com.

CHATHAM, NJ–(Marketwire – December 2, 2010) – Today, MediMedia announced the consolidation of two of its largest divisions: Krames Patient Education and StayWell Custom Communications. Industry-leaders in their respective fields, the two organizations will join forces to create a combined company that will be the largest provider of interactive and print patient education solutions and consumer health information in the country. The Krames StayWell team will have an unmatched market presence including nearly 80 sales and account executives, more than 80 product developers and designers, nearly 45 interactive solution developers and technology specialists, and 25 dedicated client services professionals. The two companies will combine into one organization effective January 1, 2011, to be called Krames StayWell.

“There is really only one reason we are taking this action, and it is a powerful one,” said MediMedia CEO Steve Simcox. “We believe that by consolidating our extensive technology and content assets, product development expertise, and client services resources, we can drive greater value for our clients.”

The consolidation is designed to build on the combined strengths of both organizations, allowing Krames StayWell to more easily offer seamless access to a wider breadth of products, consultative professional expertise, technology, and content assets. “There is no question that we can serve client needs better together than separately,” said Patrick Clifford, StayWell Company Chairman.

“Our goal is to make it even easier for our clients to do business with us,” said George Parker, President and CEO of Krames, who will serve as CEO of Krames StayWell. “We will be able to provide enterprise-wide and market-specific solutions designed to drive consumer engagement, improve health outcomes, and lower healthcare costs with unmatched ability to integrate print and interactive solutions. Krames StayWell is uniquely positioned to deliver ROI to our clients across all healthcare markets.”

The executive leadership teams of Krames and StayWell Custom Communications will remain intact, and will combine in new roles. “This is a team that has worked together for an extensive period of time, knows each other well, and thrives on the spirit of collaboration and innovation offered by this consolidation,” said Trent Sterling, President and CEO of StayWell Custom Communications, who will serve as President for the new organization. The company will have more than 330 employees located throughout the country. 

Krames StayWell will represent best-in-class health communication solutions across the entire spectrum of consumer engagement. Products from the combined organizations are used by more than 85% of American hospitals, as well as leading health plans, employers, pharmaceutical companies, retail organizations, and thousands of healthcare professionals in multiple care settings.

Krames Patient Education has a long history of creating exceptional patient education solutions, in print and interactive formats, rooted in patient-centric content created in consideration of health literacy design principles. Krames flagship products designed to initiate positive patient health self-management at the point of care include:

• Krames On-Demand™ — an electronic, print on-demand system featuring more than 5,300 single topic HealthSheet™ articles covering 38 medical specialty areas and spanning 12 languages.
• Krames Exit-Writer™ — an electronic emergency department discharge instruction program featuring more than 1,400 discharge instruction covering the most common diagnoses addressed in the ER/Urgent care environment plus a prescription writer and medication reconciliation tool.
• Krames Video Solutions™ — A suite of tools enabling delivery of more than 430 Patient Education videos spanning nine languages via websites, point of care tools, kiosks, CCTV systems and DVDs.
• Krames Patient Consent™ — An electronic system designed to standardize and streamline the informed consent process. Via the creation of personalized, procedure specific legal forms and companion patient education written in plain language, Krames Patient Consent™ ensures better patient-provider communication improving outcomes while mitigating legal risk.
• Krames Go-to-Guides™ — A suite of interactive, multimedia disease management workbooks featuring narrated text, embedded video, and quizzes for learning verification designed to match the learning preferences of almost any patient.
• Krames Print Materials™ — An award-winning library of more than 1,300 booklets, brochures, tear sheets, and other formats featuring Krames signature art-text synergy.

StayWell Custom Communications has a legacy of creating print and interactive health information and health management communications designed to help healthcare organizations engage and motivate consumers, and deliver measurable ROI. The company will contribute a wide range of award-winning solutions to the new organization, ranging across digital, mobile, print, SEO and professional services:

• Digital — interactive health libraries and health portals offer more than 30,000 interactive content assets, and include the widely used StayWell Solutions Online™ and StayWell Engage™; microsites, video, email, animations, podcasts and symptom checkers;
• Mobile — text messaging programs, mobile sites, symptom checker for the iPhone, event promotion, contact center solutions and custom applications;
• Custom Print Solutions — more than 100 million copies each year of award-winning publications and other print communications for community, member, disease management and client-selected audiences;
• Search Engine Optimization (SEO) — local search, keyword optimization and conversion optimization; and
• Professional Services — content integration consultation, Return-on-Investment (ROI) measurement, media integration strategy, and consultative strategy support for creating comprehensive multi-media communications solutions that engage consumers and deliver results.

Both organizations have been committed to helping their clients achieve better health outcomes for consumers for decades. Now united, Krames StayWell is uniquely positioned to provide comprehensive, multimedia health information and communication solutions across multiple consumer touch points — delivering the engaging healthcare information patients and consumers want, when they want it and how they want it, and with a focus on generating measurable results for their clients.

About Krames

Krames (a MediMedia Company) is the market leader in patient education and consumer health information solutions. More than 85 percent of American hospitals, as well as leading health plans, employer groups, private practices and pharmaceutical companies use Krames’ solutions to improve quality of care, streamline workflow and lower healthcare costs. Krames also brings health literacy expertise to American Heart Association/ American Stroke Association and American Lung Association patient education through exclusive partnerships with these respected organizations. Founded in 1974, Krames remains at the leading edge of patient education with innovative programs that utilize a comprehensive suite of print, electronic and video content.

For more information, please visit www.krames.com

About StayWell Custom Communications

StayWell Custom Communications (a MediMedia Company) is the leader in custom health content solutions delivered via a variety of sophisticated technology platforms. Our interactive offerings include robust web platforms, online health libraries, e-mail and mobile marketing programs, an extensive range of multimedia tools including video, podcasts and animations, and health management tools and programs. StayWell Custom Communications also offers a comprehensive range of print and print/interactive integrated solutions to meet a broad range of clients’ marketing and communication needs. The company serves hundreds of clients representing several channels in the healthcare industry: hospitals and health systems; health plans; employers; and retail organizations.

For more information, please visit www.staywellcustom.com

About MediMedia

Headquartered in Yardley, PA, with 1,700 employees in offices throughout the U.S., MediMedia changes consumer and professional behaviors through superior engagement, education and end-user preferences. Our health information services group creates, publishes, distributes, and syndicates on and off-line health information to help consumers make informed health decisions on behalf of a variety of sponsors, including providers — both hospitals and physicians, payers, and online media companies. Our health management services group provides population health management services which help consumers lower their health risk, enabling employers to lower their risks, utilization and ultimately their health care expenses. And finally, our professional segment derives its revenues from providing online/off-line professional promotion, engagement, and education services targeted to healthcare professionals and their patients

MediMedia is a Vestar Capital Partners portfolio company.

Click here to see all recent news from this company

ORLANDO, FL–(Marketwire – December 1, 2010) – WellTek, Inc. (OTCBB: WTKN), a global health, fitness and wellness company, announced today that it plans to expand into the virtual event market, specializing in the healthcare and wellness niche, by launching a new wholly-owned company, WellTek Events, Inc. This next-generation virtual event platform will serve as the foundation in allowing WellTek and other brands to actively reach, engage and influence health and wellness conscious consumers with new and existing brand assets, technologies, products and services.

According to the Virtual Conference and Trade Show Market Study 2010-2015, the worldwide virtual conference and trade show market is forecasted to grow at a compound annual growth rate (CAGR) of 56% between the period of 2010 and 2015 and to generate $18.6 billion in revenues over the period 2010 – 2015. While the virtual event market is still in its infancy, WellTek intends to launch into the virtual event business.

WellTek Events is looking to become the industry leader in producing and delivering powerful virtual events for the healthcare and wellness market — linking exhibitors, attendees, and thought leaders together in a fully immersive and engaging virtual environment. 

Without the costs, hassles and time involved in a physical event, participants navigate through the 3D game-like world booth by booth via an avatar. Advances in technology allow exhibitors to actively reach, engage and influence a highly targeted global audience, create and customize virtual booths, communicate with prospects via video conferencing and live chat, convert leads to customers in real-time with the Ecommerce platform, generate reports and analytics to tract ROI and many more features that ultimately turn prospects into buyers and customers into raving fans.

The integration of virtual events, social networking and social gaming permits attendees to overcome the challenges facing the traditional trade show market, as well as take advantage of the benefits of social media: staying in constant contact, sharing opinions, recommendations and links, getting answers right away and feeling connected to the information they care most about — all while being entertained.

Randy Lubinsky, Chairman and CEO of WellTek, stated, “With over 40 years experience in the medical industry and interacting with physicians, we believe we can leverage our expertise to establish WellTek Events as the premiere company for virtual medical conferences and wellness events.”

In an effort to focus time and capital on WellTek Events, the company has decided to rescind the acquisition of its 51% interest in WellCity, Inc. As part of the rescission, 14,500,000 shares of WellTek common stock will be returned to WellTek and the financial position of both companies will return to that prior to the May 1, 2010 acquisition.

In addition, WellTek has also effectuated a 50 to 1 reverse split as of December 2, 2010 in order to facilitate raising additional growth capital.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellTek Events, Inc., a fully engaging virtual event platform specializing in the healthcare and wellness market. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please contact [email protected] or visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

MISSION, KS–(Marketwire – December 1, 2010) – PPM Information Solutions, Inc. (PPMIS) (www.ppmconnect.com) publishes “The Practice Readiness Roadmap — your route to a successful start.” Dedicated to serving the anesthesia community, PPMIS is forging its presence in the medical community and delivering its guide for assisting physicians who are considering starting a practice or moving to a new software vendor or billing service. Download a free copy.

For over a decade, PPMIS has developed first-rate software for medical billing solutions. Formed by anesthesiologists to serve the anesthesia specialty, the company’s goal is providing its clients with industry-leading software products and services. Because PPMIS understands the complexity of billing for anesthesia, its products and services take the everyday complications out of medical billing.

The company’s newest platform, a SaaS model, is medical billing software with flexibility, a full range of reporting options, and strictly enforced exception edits, ensuring claim accuracy that result in prompt reimbursement. The fully integrated Connect platform provides accelerated claims processing, streamlined collections management, and reporting capabilities.

RCM Services, its full-service medical billing service, offers multi-specialty billing, certified coding, SaaS technology, demographic and EMR downloads, payer credentialing, and practice advocacy. Proven metrics ensure the success of the client’s practice. The company believes when the client succeeds, it succeeds. Learn more about PPMIS practice management services.

About PPM Information Solutions, Inc.
PPMIS is a medical billing provider that helps clients recognize revenue faster by submitting clean claims. The company offers both billing software and billing services as its medical billing solutions. This U.S. based company does 100% of its software development at its headquarters in Mission, KS. Its staff is dedicated to delivering the most comprehensive solutions available for medical billing. PPMIS billing solutions and the Practice Readiness Roadmap free practice assessment can be found at www.ppmconnect.com.

Direct inquiries to [email protected], or contact Manolito Jones or Dan Olin at 913-262-2332 to request a product demonstration.

Click here to see all recent news from this company

PLYMOUTH MEETING, PA–(Marketwire – November 29, 2010) – In advance of the first randomized, placebo-controlled clinical trial in the world of its type for Alzheimer’s disease and other dementias, Quietmind Foundation (QMF), Plymouth Meeting, Pa., is honored to host two presentations by Gordon Dougal, M.D., a National Health Service physician, inventor, and dementia researcher from Durham, U.K. Dr. Dougal will discuss the application of 1072nm infrared light therapy in the treatment of dementia. The presentations will include the pioneering research findings from studies conducted by Dr. Dougal’s colleagues at Durham University on the effects of this type of phototherapy on neuroprotection and beta amyloid plaque deposition and abeta42 oligomer levels.

Professional colleagues, caregivers, and family members of people struggling with neurodegenerative disorders are cordially invited. The free programs will take place on Sunday, December 12, from 4:00 p.m. to 5:30 p.m., and Monday, December 13, from 11:30 a.m. to 1:00 p.m., at the QMF offices, 521 Plymouth Rd., Suite 111, Plymouth Meeting, Pa., 19462. Light refreshments will be served.

Each program will begin with a brief scientific overview by Dr. Dougal directed toward professionals working in research and clinical care of people struggling with dementia. Marvin Berman, Ph.D., QMF’s president, will then discuss the foundation’s previous research in dementia and current clinical work. Following will be a demonstration of the 1072nm infrared light therapy and overview of parameters of the clinical trial to be conducted at the QMF offices.

For a fuller description of the upcoming clinical trial utilizing the 1072nm technology for the treatment of early stage dementia: http://clinicaltrials.gov/ct2/show/NCT01059877?term=1072&rank=3

About Quietmind Foundation

Quietmind Foundation, a 501(c)3 nonprofit founded in 2000, is an international center for cutting-edge research and consultation in the use of brainwave (EEG) biofeedback and related technologies. Its ongoing research agenda — and the nondrug, noninvasive treatments offered through its affiliate, Quietmind Associates — focuses on the spectrum of neurodegenerative disorders, including dementia, Parkinson’s, ALS, and MS as well as traumatic brain injury, PTSD, and learning disabilities. Its goal is to integrate innovative technologies and evidence-based behavioral interventions into governmental, public health, and educational service delivery systems.

QMF’s prior research on Alzheimer’s disease was accepted for presentation at the July 2009 International Conference on Alzheimer’s Disease (ICAD) in Vienna, Austria. This research demonstrated improvements in subjects’ memory, executive function, and psychiatric symptoms, and a reduction in medications.

For further information and reservations for either presentation: 610-940-0488 or [email protected]

Click here to see all recent news from this company

CHICAGO, IL–(Marketwire – November 29, 2010) – Sami Bittar, M.D., has added a new, noninvasive fat-trimming procedure — known as CoolSculpting by ZELTIQ™ — to the aesthetic services he offers patients.

Recently seen on The Dr. Oz show, the CoolSculpting procedure is completely noninvasive, using no needles and no incisions, to selectively reduce fat bulges. The procedure uses a non-invasive applicator, applied to the skin surface, to deliver a controlled cooling to target areas. After exposure to the cooling, fat cells begin to be gradually eliminated, using the body’s normal metabolic processes. Most patients can read, listen to music or relax during the procedure and return to their normal activities on the same day as the procedure.

Benefits of the CoolSculpting by ZELTIQ™ include:

• A reduction in fat bulges in about two to four months, with the most dramatic results occurring after two months.

• A 20 percent reduction in the fat layer.

The CoolSculpting procedure is based on a science called Cryolipolysis™, a groundbreaking discovery by Drs. Dieter Manstein and R. Rox Anderson of Harvard Medical School and the Wellman Center for Photomedicine at Massachusetts General Hospital in Boston that subcutaneous fat cells are more vulnerable to the effects of cold than the surrounding tissue and that fall cells will be reduced after exposure to cold through a process called “induced apoptosis.”

Dr. Bittar works collaboratively with his patients to help create a more aesthetically pleasing physique. His practice currently offers liposuction, abdominoplasty, breast augmentation, reduction and reconstruction as well as face lifts and nose surgery.

More information about CoolSculpting™ by ZELTIQ™ is available at www.coolsculpting.com. Visit http://www.samibittarmd.com or call (708) 354-4667 for more information about Dr. Bittar and the services he provides.

Sami M. Bittar, MD, FACS is a board-certified Plastic and Reconstructive Surgeon with extensive experience in the field of aesthetic and reconstructive plastic surgery of the face, breast, and body. Visit http://www.samibittarmd.com or call (708) 354-4667 for more information.

COLUMBUS, OH–(Marketwire – November 23, 2010) – The adage “Choose a job you love and you will never have to work a day in your life” may well be true at Quantum Health. The company, after all, was recently recognized both locally and nationally as of one of America’s best places to work by two different publications.

In the 2010 Great Place to Work^® Rankings of the Best Small & Medium Workplaces presented by Entrepreneur^® magazine, Quantum Health ranked 23^rd among the “50 Best” companies nationally. Columbus’s Business First also highlighted the company as a 2010 “Best Places To Work” in its small companies category. Quantum Health is a four-time recipient of this award and earned second place honors in this year’s competition — one spot higher than its third place finish in 2009.

“Quantum Health’s success in delivering value to its clients rests solely on recruiting, hiring and retaining the area’s best employees,” said Kara Trott, CEO. “We’re thrilled to be recognized as a great place to work by our employees and believe that it translates into great service to the people we serve every day.”

The Entrepreneur “50 Best” are selected and ranked by Great Place to Work^® Institute, Inc., a workplace research and consulting firm. The determination of the best 50 companies is guided by a methodology that places the greatest weight on their responses to the survey, which accounts for two-thirds of the total score. The remaining one-third of the score comes from the Institute’s evaluation of each company’s culture. Companies are scored in five distinct areas: credibility, respect, fairness, pride and camaraderie.

Columbus Business First’s 2010 “Best Places To Work” honorees were chosen using an independent firm’s proprietary employee survey methodology and software to evaluate nominees. Companies were judged solely upon quantitative measurement of employee input.

ABOUT QUANTUM HEALTH
Quantum Health is an award-winning and fundamentally different healthcare company headquartered in Columbus, Ohio, serving employers nationally.

Quantum Health guarantees its clients a 5-8% reduction in total claims spend. By reorganizing benefits delivery and creating a “virtual medical home” for each member, Quantum Health maximizes each service opportunity to intercept patients when they have a problem to solve or questions about their benefits or healthcare. Real time, informed involvement allows our Care Coordinators to help patients, their families, and their physicians to work together to ensure proper care, eliminating redundant, delayed and questionable care — literally driving unnecessary medical events and cost out of the system. All with a 100% guarantee.

DURHAM, NC–(Marketwire – November 23, 2010) – Mi-Co announced today the release of a new application for the Windows Phone 7 platform from Microsoft that will allow physicians, nurses and other healthcare professionals to lookup ICD9 codes for various disease conditions on the go. Documentation in healthcare frequently requires lookups of diagnosis codes for various disease states and the entry of those codes on forms for reimbursement, patient processing and more.

With Mi-Co’s ICD9 application, healthcare professionals using Windows Phone 7 devices can have access to the various codes literally anywhere, fitting their mobile workflow. As of this date, this is the only ICD9 reference application on the Windows Phone Marketplace. Chris DiPierro, Director of Software Development for Mi-Co, says “We see various app-based smartphone marketplaces as important in the future, for enterprises as well as consumers. This ICD9 application showcases the versatility of Mi-Co’s ability to design mobility-oriented healthcare software for a variety of different platforms and needs.“

To get Mi-Co’s ICD9 application, search for “ICD9” in the Windows Phone Marketplace.

Learn more about how applying electronic mobility to your data collection processes can streamline and positively impact workflows in your enterprise. Visit us at: www.mi-corporation.com or email us at [email protected].

About Mi-Co

Mi-Co, a leading provider of mobile data collection solutions, provides software to automate paper forms-based business processes. Mi-Co’s enterprise Mi-Forms Software System provides flexible electronic forms design for data capture using digital ink and has proven capabilities for the communication of forms-based data. Mi-Forms support Tablet PCs, Digital Pens, iPads, Pocket PCs, signature capture devices and industry standard software technologies. Mi-Co reaches historically paperwork intensive markets such as healthcare and government and supports an extensive network of channel partners. For more information on Mi-Co, visit www.mi-corporation.com

Click here to see all recent news from this company

FORT COLLINS, CO–(Marketwire – November 23, 2010) – Available for various BlackBerry^® smartphones, the pink OtterBox^® “Strength” line now offers protection for the BlackBerry^® Torch^™ 9800 smartphone. These innovative Commuter Series^® cases are a stylish way to keep the BlackBerry Torch smartphone pristine while supporting a good cause. OtterBox donates 10 percent of the purchase price from each “Strength” case to the Avon Breast Cancer Crusade to support research to find a cure for breast cancer and programs that provide access to breast health care, regardless of a person’s ability to pay.

“Supporting the Avon Breast Cancer Crusade has been an amazing opportunity for OtterBox and our customers,” said OtterBox founder and CEO Curt Richardson. “We’ve enjoyed the reveal of each new ‘Strength’ case and to date have donated more than $80,000 to the cause.”

The OtterBox Commuter Series case for the BlackBerry Torch smartphone is unlike any other case on the market, providing customized layers for extra protection. First, a white silicone skin fits snuggly around the back with plugs that fit precisely into all ports to prevent damage from dirt and dust. Second, a pink polycarbonate shell snap onto the front and another piece to the back allowing full functionality of the phone’s sliding feature and touch screen. The case also includes a self-adhering screen protector to keep the display scratch free.*

See the complete pink line for all you BlackBerry smartphones, available at www.otterbox.com/strength. 

Additional information for OtterBox Commuter Series for the BlackBerry Torch 9800 smartphone:

Environmental Protection:

• Added protection against bump and shock

Colors:

• Silicone: white
• Polycarbonate: pink

Dimensions (case only):

• 4.56″ (115.71 mm) x 2.64″ (67.11 mm) x 0.72″ (8.28 mm)

Approximate Weight (case only):

• 0.80 oz (22.68 g) 

About the Avon Breast Cancer Crusade:

The Avon Foundation for Women’s Avon Breast Cancer Crusade has supported programs in more than 50 countries since its creation in 1992 and to date has raised and awarded more than $640 million worldwide for advancing access to care and finding a cure for breast cancer, with a focus on the medically underserved. Funding supports five areas: awareness and education; screening and diagnosis; access to treatment; support services; and scientific research. For more information or free printable breast cancer information, visit www.avonfoundation.org. For information about participating in the Avon Walk for Breast Cancer events, visit www.avonwalk.org.

About OtterBox:

Built upon fundamentals of hard work, innovation and perseverance, OtterBox is a leader in the production of premier protective solutions for global handheld manufacturers, wireless carriers and distributors.

Incorporating creativity and cutting-edge design into every product, OtterBox creates sleek and durable cases that offer reliable device protection to complement any lifestyle.

OtterBox was founded in 1998 and is headquartered in Fort Collins, Colo.

For more information, visit www.otterbox.com or call 888-695-8820. We’ve Got Technology Covered.

Notes:

*Commuter Series cases NOT protected against water. Will provide some added protection against bump and shock.

The BlackBerry and RIM families of related marks, images and symbols are the exclusive properties and trademarks of Research In Motion Limited.

©2010 Otter Products, LLC. All rights reserved. OtterBox and all OtterBox logos, trademarks and symbols are the property of Otter Products, LLC.

Click here to see all recent news from this company

CHICAGO, IL–(Marketwire – November 23, 2010) – GoHealthInsurance.com, the online marketplace for health insurance comparison shopping, is offering consumers a friendly reminder and help for how they can use their Flexible Spending Account (FSA) funds before they expire at the end of December.

“It’s getting towards the end of the year and any funds leftover in a Flexible Savings Account will be forfeited for 2011. Consumers should make sure they check their FSA balances and utilize any savings before it’s lost,” said Mark Colwell, Consumer Marketing Analyst at GoHealthInsurance.com.

Have a FSA but don’t know how to use the saved funds before they expire? Here are a few tips:

• With the flu season right around the corner, one easy way to spend leftover money is to get flu shots and any vaccinations that are not up to date.

• Schedule physicals, wellness and routine care visits with your family doctor to ensure that everyone in the family gets an annual check-up.

• Purchase over-the-counter medication that you and your family typically use. Starting in 2011, FSA funds can longer be used on over-the-counter medications without a prescription. Medications that will require a prescription from a doctor include allergy and asthma, cold and flu, pain relief, anti-itch, antacids and acne medication.

• Next year, consider the benefits of Health Savings Accounts (HSAs) with high-deductible health plans. The funds in HSAs roll over every year and earn interest.

Consumers can compare individual health insurance options, including plans compatible with Health Savings Accounts, at www.gohealthinsurance.com.

About GoHealthInsurance

GoHealthInsurance.com makes buying health insurance simple. GoHealthInsurance explains health coverage options in plain English, provides free health insurance quotes, connects shoppers with local agents, and helps consumers choose plans that meet their health and budget needs — making it the most robust health exchange.

Click here to see all recent news from this company

WEST PALM BEACH, FL–(Marketwire – November 23, 2010) – For many of the millions of hearing impaired Americans, especially the 27 million living with untreated hearing loss, the holidays may not be all that happy, says audiologist Dr. Cindy Beyer.

Dr. Beyer, senior vice president of HearUSA, Inc. (NYSE Amex: EAR), one of America’s largest hearing care and hearing aids companies, said, “Studies have linked hearing loss to stress, frustration, and social isolation, which can easily be intensified at holiday gatherings with families and friends, when many of those with hearing impairment may find conversations both difficult and isolating.”

“Hearing loss is often labeled ‘the invisible handicap’ because there are no outward signs of a handicap or limitations,” said Dr. Beyer. “As a result, we are unlikely to be aware that accommodations may be necessary to avoid a breakdown in communication.”

Dr. Beyer offers suggestions for making holiday meals and celebrations more comfortable and enjoyable for those with hearing impairment, as well as for the people around them.

• Speak clearly and distinctly, but not too fast — and never shout.
• If you are asked to repeat something, do so without raising your voice and appearing annoyed.
• If your comment or question is still not being understood after repetition, reword it. Some words are easier to understand than others.
• In a group situation, be sure the hearing-impaired person is included in the conversation. If not, bring them back in.
• When speaking, look directly at the person and try not to be more than five feet away. 
• Your facial expressions, gestures and overall body language are important aids in communicating, so try to be sure you have the listener’s attention and that the room is well lit.
• Conversation is greatly enhanced when there is no distracting background noise from a radio or television.
• Dining out? Choose a quiet restaurant. Noisy conversations and the clatter of dishes and tableware in a crowded dining area are barriers to effective communication.
• Ask if there is anything you can do to make communication easier. For example, conversation will be much easier to understand in a room with carpeting and well-upholstered furniture than in a room with tiled floors, high ceilings or wooden furniture.

While almost all hearing loss can be successfully treated with hearing aids, only 25% of the 36 million Americans with hearing loss have hearing aids, according to the Better Hearing Institute. They note that most hearing aids users report significant improvement in their interpersonal relationships and social lives.

“Today’s digital hearing aids are smaller, smarter and more comfortable than ever before,” added Dr. Beyer. “During this holiday season, I can think of no kinder act than encouraging a loved one or a friend with untreated hearing loss to consider the positive impact hearing aids could have on their lives, and help them arrange for an evaluation by a licensed hearing care practitioner.”

About HearUSA
HearUSA, Inc. (NYSE Amex: EAR) is the recognized leader in hearing care for the nation’s top managed care organizations through its network of more than 2,000 hearing care providers and 176 company-owned centers. HearUSA is the nation’s only hearing care network accredited by URAC, an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. HearUSA is also the administrator of the AARP Hearing Care program, designed to help millions of Americans aged 50+ who have untreated hearing loss. For more information about HearUSA visit www.hearusa.com.

SEATTLE, WA–(Marketwire – November 23, 2010) – ECG Management Consultants, Inc., one of the nation’s premier healthcare management consulting firms, today announced the release of its eleventh annual Northwest Provider Compensation, Production, and Benefits Surveys.

ECG’s Northwest surveys analyze and report information from over 4,200 healthcare providers representing 56 physician specialties and 8 midlevel provider specialties in the states of Washington and Oregon. The surveys contain critical data such as compensation-to-production ratios, including work and total relative value units (RVUs), procedure code distributions, trends in provider recruiting and retention, and specialty-specific benefit and malpractice comparisons. This information, coupled with ECG’s interpretation of market trends, enables survey participants to assess their performance relative to the competitive local market.

General findings in the 2010 surveys based on 2009 data are as follows:

• Compensation relative to work RVU production increased for Northwest physicians by 6.1 percent as a result of compensation gains of 5.2 percent on declining work RVU production of 1.1 percent.

• Retirement contributions remained flat at $13,351 per physician, while benefit costs overall fell to 17.9 percent of compensation as a result of increased compensation levels, even though actual costs continue to rise.

• The top three recruited specialties in the Northwest for the fourth year in a row include family practice without OB, internal medicine, and internal medicine – hospitalists.

• Health system-employed groups continue to experience significant losses (approximately 23 percent of collections), while independent groups are borrowing funds or accessing reserves equal to 1 percent of collections to cover expenses in excess of revenue.

• Provider organizations are targeting 191 percent of Medicare reimbursement for their commercial contracts for professional services, up from 178 percent in 2009. In reality, organizations are earning 187 percent for these same contracts.

“ECG’s Northwest surveys, now in their eleventh year, have become the most reliable source for physician performance benchmarks and trends in the Northwest,” said Ms. Maria C. Hayduk, Senior Manager at ECG and head of its Custom Survey and Proprietary Research practice. “Our members value receiving the most up-to-date information regarding regional and national trends in physician performance and compensation methodologies. This information is made even more critical as these areas are impacted by healthcare reform.”

“Continuing economic pressures and healthcare reform have been the story of 2010 for physician organizations in the Northwest,” stated Mr. Kevin M. Kennedy, Principal and leader of ECG’s Healthcare – Northwest practice. “The changing strategic landscape means it is more important than ever for both independent and hospital-affiliated practices to build groups of motivated, aligned physicians. Our surveys are the premier source of information organizations need for recruiting and retaining their key providers to accomplish this objective.”

ECG Survey Methodology
The Provider Compensation, Production, and Benefits Surveys are developed in partnership with local healthcare leaders and ECG’s physician compensation and production experts. These experts go to extraordinary lengths to ensure data quality and validity. Raw survey data is reviewed by ECG’s survey analysts, who identify outliers for verification by the surveys’ participants; if data cannot be validated, it is removed. At the conclusion of this process, ECG converts the raw data into succinct, proprietary information.

About ECG Management Consultants, Inc.
ECG offers a broad range of strategic, financial, operational, and technology-related consulting services to healthcare providers. ECG provides specialized expertise in developing and implementing innovative and customized solutions that effectively address hospital/physician relationships, strategic and business planning, specialty program development, information technology, and the complexities of the academic healthcare enterprise. ECG has offices in Boston, San Diego, Seattle, St. Louis, and Washington, D.C. For more information, visit www.ecgmc.com. 

Click here to see all recent news from this company

TORONTO, ONTARIO–(Marketwire – Nov. 23, 2010) – The ultimate family funfest Funday Sunday arrives on November 28, 2010 to entertain Torontonians of all ages in support of Sunnybrook’s Women & Babies Program and the Canadian Hadassah-WIZO Toronto (CHW), which is dedicated to the health care of women and children in Israel. The event will run from 9 a.m. to 5 p.m. at the Metro Convention Centre, and with family passes priced at only $39, this is one event that Toronto families will not want to miss!

Presented by Dancap Productions, Funday Sunday offers something for everyone:

• a marketplace with designer goods and deep discounts
• a Children’s Village with bouncy castles, face painting, games and talented performers 
• a fun zone with an arcade and a skateboard park for teens
• an “ask an health expert” booth hosted by Sunnybrook staff

“We are honoured to have the support of this joint partnership between Sunnybrook and the CHW,” says Dr. Andrew Shennan, chief of the Women & Babies Program. “A part of the proceeds from Funday Sunday will help our world-class staff continue to deliver the highest level of care in what is now one of the most advanced maternity wards in North America.”

The new Women & Babies facility at Sunnybrook officially opened its doors to the public in September 2010. This 120, 000 square foot facility, which has received international acclaim for its leading-edge design, will now be able to accommodate up to 4,250 births each year – 500 more births than the previous facility.

“CHW Toronto’s partnership with Sunnybrook allows us to continue the important work of supporting our most vulnerable women and children,” says Sarah Granatowicz, president of the Canadian Hadassah-WIZO Toronto. “CHW has a long and rich history of supporting children, healthcare, and women both here in Toronto and in Israel.” 

For more information about Funday Sunday or to register online, visit fundaysunday.ca or email [email protected].

About CHW

Founded in 1917, Canadian Hadassah-WIZO (CHW) Organization of Canada is a non-political women’s volunteer organization dedicated to the support of education, career training, healthcare, women and youth services in Israel and Canada.

About Sunnybrook Health Sciences Centre’s Women & Babies Program

At Sunnybrook, women and babies get the very best care available, delivered in a family-centred environment. With a focus on high-risk pregnancy and critically premature babies, Sunnybrook accepts more emergency maternal transfers than any other hospital in Ontario.

WATERLOO, ONTARIO–(Marketwire – Nov. 23, 2010) – The Waterloo Wellington community is working diligently to ensure that young people who are struggling with addiction and mental health issues are getting the help they need. But treatment is only one part of the equation. When it comes to addiction and mental health issues and youth, an ounce of prevention really is worth a pound of cure.

The Education and Training Working Group of the Waterloo Wellington Addiction and Mental Health Network is turning the focus to prevention by bringing Dr. David Wolfe, a psychologist and author specializing in issues affecting children and youth at the Centre for Addiction and Mental Health (CAMH) Centre for Prevention Science, to Waterloo on November 26th to speak about youth risk and resiliency.

The event being held at Luther Village is at capacity, with over 170 community members registering to attend including City of Waterloo Mayor Brenda Halloran and Kitchener – Waterloo MPP Elizabeth Witmer.

Approximately 26% of Ontario students in grades 7 through 12 used cannabis in the past year, peaking at 46% in grade 12. A quarter of grade 12 students report being drunk or high at school within the past year. These statistics from the Ontario Student Drug Use and Health Survey (2009, CAMH) are just the tip of the iceberg.

Our young people are also experiencing emotional and mental health issues at disturbing rates. More than 30% of students in grades 7 to 12 reported elevated psychological distress. About 10% of students reported they had seriously considered suicide in the past year.

Being resilient is no guarantee that a person will not experience challenges. Resilience means having the ability to face difficulties and move forward from them. Resilient youth tend to be empathetic and adaptable with good communication and problem solving skills. They tend to have future goals and be hopeful about what they can achieve. Young people’s resilience is determined by a number of things including individual characteristics, the characteristics of their families, and the physical and social environments where they live.

Building resilience in our young people is not easy but we can teach them skills that will help them cope with problems they may encounter. By developing these skills and creating supportive relationships, young people are more likely to be protected from life’s challenges, including substance use and mental health problems.

Dr. Wolfe’s presentation will address coping and resilience, review best practices for development of effective substance use and mental health prevention programs, and provide examples of community and school based initiatives that help youth build healthy relationships.

The Education and Training Working Group intends for this event to be a starting point to increase collaboration, coordination, and impact of youth substance use and mental health prevention in Waterloo Wellington.

To register, please contact Paul Radkowski, [email protected].

The Addiction and Mental Health Network is made up of many people with lived experience, families, agencies and committees within Waterloo Wellington who are committed to working together to develop a seamless and integrated system of mental health and addiction services. The Network works in partnership with the Waterloo Wellington Local Health Integration Network to ensure that the Mental Health and Addiction priorities identified in the Integrated Health Services Plan are achieved. For more details about the vision and objectives of the Network, please visit www.wwamh.ca.

PLANTATION, FL–(Marketwire – November 23, 2010) – Transax International Limited (Transax) (PINKSHEETS: TNSX), a network solutions company for healthcare providers and health insurance companies, today reported financial results for the first nine months of 2010 and third quarter ended September 30, 2010.

For the quarter ended September 30, 2010, Transax generated net revenues of $1,211,511 compared to $1,155,060 in net revenues during third quarter of 2009, a 4.9% increase. The increase in revenues is principally due to the continued roll out of new contracts signed during the previous year and organic growth from existing clients. Transaction volume increased to 2.61 million for the third quarter of 2010 with some 66% of transactions being performed by the company’s proprietary Web based solution compared with 50% during the same period in 2009.

Loss from operations in the third quarter of 2010 was $332,240 compared with a $448,694 loss during the same period in 2009 a decrease of 26%. The Company recorded a loss prior to income taxes, for the third quarter of 2010 of $460,823 compared with Income prior to income taxes of $1,781,821 in the third quarter of 2009. The increase in loss was principally due to a reversal from the gain in the fair value of the recording of derivative liabilities.

For the nine months ended September 30, 2010 revenues increased by 2.5% to $3,280,772 from $3,201,083 during the same period in 2009. The increase in revenue is predominantly due to increase in roll out of the additional solutions. The Company recorded a loss from operations of $1,271,420 for the nine months ending September 30, 2010 compared to a $1,009,865 loss from operations during the same period in 2009. The increase in loss is primarily attributed to increases in general and administrative costs and compensation expenses. Net Loss for the first nine months of 2010 was $1,828,306 compared to Net Loss of $1,939,994 during the same period in 2009.

At the end of the third quarter 2010 the Company had 24,833 solutions operational in Brazil including over 3,100 Point of Sales (POS) Solutions. During the nine months ended September 30, 2010 the company installed approximately 7800 Web solutions and disconnected over 100 Interactive Voice Response (IVR) Solutions allowing for greater operational flexibility and increased functionality for the client. The Company undertook 7.1 million real-time transactions during the nine months ending September 30, 2010 compared to 6.3 million transactions during the same period in 2009. The Company has twelve contracts in place in Brazil eleven of which were generating revenues and one under a pilot test environment. At the end of the third quarter 2010 approximately 68% of the Company’s transactions were being undertaken by the Company’s Web solution compared to 52% at the start of 2010.

In announcing the results Stephen Walters, President & CEO, stated, “Since January 2010 revenues have increased approximately 19% in line with the transaction volume which has increased from 2.2 million in the first quarter of 2010 up to 2.6 million transactions for the third quarter 2010. The company continues to seek operating efficiencies to reduce costs and operational losses while undertaking continued development of its product in the Brazil market place.” 

About Transax International Limited

Transax International is an emerging network solutions provider for the healthcare sector. Utilizing its proprietary MedLink™ technology, Transax provides a service similar to credit card processing for the health insurance and providers industries. A transaction consists of: approving eligibility, authorization, auto-adjudication of the health claim and generating the claim payable files — provided instantaneously in “real time” — regardless of method of claim generation.

Transax’s solutions have been proven to significantly decrease health insurance claim expenditures and healthcare provider costs. Based in Plantation, Fl, Transax maintains a major operations office in Rio de Janeiro, Brazil with approximately 40 staff and a Sales Office in Sao Paulo, Brazil. The Company has contracts in place with major health insurers in Brazil and currently undertakes approximately 850,000 transactions per month.

SAFE HARBOR STATEMENT: “THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY’S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE ‘SAFE HARBOR’ PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.”

SANTA MONICA, CA–(Marketwire – November 22, 2010) – The first annual Grayson’s Gift Foundation Event, hosted on November 11, 2010, was a huge success, raising more than $150,000. The charity event took place in the ballroom at Hotel Casa del Mar in Santa Monica.

Grayson’s Gift Foundation is a non-profit committed to raising money for the brain cancer research department at the Children’s Hospital of Los Angeles. Money was raised through ticket sales, an extravagant silent auction, and generous donations made by attendees.

The Grayson’s Gift Foundation was founded in 2010 by Leslie and Cliff Katab, whose son Grayson died from a brain tumor just over two years ago. Cliff Ketab said, “We went through many surgeries and chemo and countless days in hospitals, as well as traveling to Europe for experimental treatments. Although we did everything humanly possible, we lost our beloved baby boy two years ago.

“Pediatric brain cancer is the second leading cause of children’s death only behind social causes (car accidents, etc). Being immersed in this world taught us many life lessons. One thing we know is that we must help find a cure for these children. We created Grayson’s Gift Foundation just for this reason. Our charity donates its contributions directly to support research and training for pediatric brain cancer.”

A festive evening, it was a fusion of determined oncologists, compassionate celebrities, friends and family. Thrown into the mix were individual demonstrations of state-of-the-art brain-computer controlled games using NeuroSky technology. The day before the event, NeuroSky donated several games to the pediatric cancer ward at Children’s Hospital Los Angeles. At the event, David Westendorf, Vice President of NeuroSky, talked about how Children’s Hospital LA saved his niece’s life, and then he gave away NeuroSky-powered Mindflex games from Mattel as table prizes.

Celebrity guests included: actor Jonathon Goldsmith, recognized as “The Most Interesting Man in the World” in recent Dos Equis commercials; Corey Feldmen of “The Goonies”; Taylor Armstrong of Bravo’s “Real Housewives of Beverly Hills”; Vienna Girardi who starred in ABC’s “The Bachelor”;” Jennifer Elise Cox, known for her appearance in The Brady Bunch Movie; actress Delphine Chaneac; and actor James Preston of “The Gates.”

Photos: http://www.ballantinesbiz.com/Green_Oct_2010/CHLA/CHLA_GraysonsGift_112210.html

Click here to see all recent news from this company

MENOMONEE FALLS, WI–(Marketwire – November 22, 2010) – Assisted Living Concepts, Inc. (NYSE: ALC) stated today that it is disappointed with recent actions taken by the New Jersey Department of Health and Human Services and disputes allegations in an order issued by the Department on Friday, November 19, 2010. ALC will pursue appropriate legal remedies for dismissal of the order and related penalties.

“While at certain of our New Jersey buildings we have removed the assisted living licenses and changed our operations over to independent living communities, we are still in the process of registering those buildings with the New Jersey Department of Community Affairs as either multiple dwellings or boarding homes,” stated Laurie Bebo, President and Chief Executive Officer. “This registration process can be lengthy. In the interim, we have demonstrated that seniors living in these retirement communities either receive no health care services or receive services from a variety of home health or personal companion service companies just like many senior living communities in New Jersey. We are not marketing these buildings as assisted living facilities and the staff employed by these communities provides no health care services. We believe the communities will become registered as multiple dwellings or boarding homes under New Jersey’s Department of Community Affairs.

“We are disappointed with the recent actions by the Department of Health and Human Services as they are fully aware of our ongoing participation in the administrative registration process with the Department of Community Affairs. We hope the bureaucratic process will move along more quickly and look forward to an open dialogue with the Department of Community Affairs to accomplish the registrations. We continue to meet the expectations of the tenants who reside with us and believe last Friday’s action by the Department of Health unnecessarily creates disruption for the peace of mind and well being of our tenants and their families.” 

About Us

Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,305 residents in 20 states. ALC’s senior living residences typically consist of 40 to 60 units and offer residents a supportive, home-like setting and assistance with the activities of daily living. ALC employs approximately 4,100 people.

Forward-looking Statements

Statements contained in this release other than statements of historical fact, including statements regarding anticipated financial performance, business strategy and management’s plans and objectives for future operations, including management’s expectations about improving occupancy and private pay mix, are forward-looking statements. Forward-looking statements generally include words such as “expect,” “project,” “point toward,” “intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,” “strategy” or “objective.” Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. In addition to the risks and uncertainties referred to in the release, other risks and uncertainties are contained in ALC’s filings with United States Securities and Exchange Commission and include, but are not limited to, the following: changes in the health care industry in general and the senior housing industry in particular because of governmental and economic influences; changes in general economic conditions, including changes in housing markets, unemployment rates and the availability of credit at reasonable rates; changes in regulations governing the industry and ALC’s compliance with such regulations; changes in government funding levels for health care services; resident care litigation, including exposure for punitive damage claims and increased insurance costs, and other claims asserted against ALC; ALC’s ability to maintain and increase census levels; ALC’s ability to attract and retain qualified personnel; the availability and terms of capital to fund acquisitions and ALC’s capital expenditures; changes in competition; and demographic changes. Given these risks and uncertainties, readers are cautioned not to place undue reliance on ALC’s forward-looking statements. All forward-looking statements contained in this report are necessarily estimates reflecting the best judgment of the party making such statements based upon current information. ALC assumes no obligation to update any forward-looking statement.

MUNDELEIN, IL–(Marketwire – November 22, 2010) – Educational guides on wound dressing packages can lead to increased patient safety and greater accuracy when applying the product, according to a just-released study in the Journal of Wound Ostomy and Continence Nursing (Journal of WOCN).  Published in the November/December issue of the peer-reviewed Journal of WOCN, the study included 173 clinicians and found that the nurses who used wound care dressings that had educational instructions attached to the outer package were 88 percent more likely to apply the products correctly than nurses who used the dressings in a traditional package.

“The results clearly show that just-in-time education in the form of educational instructions on a dressing package improves nurses’ confidence and accuracy when applying the dressing,” said Dea Kent, MSN, RN, NP-C, CWOCN, the author of the study and the manager of the Wound Ostomy Clinic at Riverview Hospital in Noblesville, Indiana. “The implication for manufacturers of wound dressings is that they should make it hard for the nurse to do the wrong thing by providing clear, easy-to-understand instructions that are accessible on the outside of the package so the nurse can review the process before treating the patient.”

The study used a wound dressing packaging system from Medline Industries, Inc. based on a concept of “just-in-time” education. Instructions for appropriate dressing use are attached to each package. The study was undertaken to assess the effects of this educational resource. The wound dressing used in the study was not familiar to the participants in order to more accurately assess the effect of the educational packaging and self-reported confidence with application.

The participants were randomly divided into two groups: a control group receiving the traditional wound education and an “intervention” group using Medline’s just-in-time educational packaging. None of the 62 nurses in the control group (using the traditional packaging) were able to apply the dressing correctly as compared to 68 of the 77 (88%) in the intervention group.

Similarly, 88% of the nurses in the intervention group reported that the educational packaging gave them confidence that they can correctly apply the dressing. Moreover, 71% in this group said they would change their nursing practice in relation to application of wound dressings based on the education on the package.

“The study findings provide evidence that manufacturers of wound dressings should apply just-in-time education techniques by placing an educational guide on all wound dressing packages in order to enhance the accuracy and safety of application and, ultimately, its efficacy in wound healing,” said Kent in the study’s conclusion.

Kent attributed the application failures by the nurses in the control group to a lack of knowledge about dressing application, since no information was available on the dressing package itself.

The study included nurses from a variety of backgrounds possessing all levels of education ranging from licensed practical nurse to Master of Science in nursing. Both novice and seasoned nurses were included. The study was conducted at eight facilities in central Indiana, including community hospitals, critical access hospitals, long-term care acute units, long-term care facilities and home health agencies.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

SUNNYVALE, CA–(Marketwire – November 22, 2010) – Healthmed Services, Ltd. (PINKSHEETS: HEME) announced that it has entered into a software development agreement with Veritas Software Systems. Veritas will produce for Healthmed 10 exclusive healthcare software suite systems by December 2011. “Healthmed is committed to bridging the information technology gap that plagues doctor, patient, and practice related issues that keep professionals and patients from experiencing the highest level of care and efficiency,” stated CFO Dale Paisley. Healthmed will continue to be committed to expanding its inventory of products to meet every aspect of efficiency and care, in additional to maximizing internal corporate growth and profitability.

Please read more about the Company and its product developments on its website: www.healthmedltd.com.

Notice Regarding Forward-Looking Statements

This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed with the Securities and Exchange Commission.

CINCINNATI, OH–(Marketwire – November 22, 2010) – In the midst of flu season, millions of Americans are rushing to get vaccinated before becoming one of the approximately 200,000 flu victims the Centers for Disease Control (CDC) estimates are hospitalized every year. They aren’t the only ones suffering: according to study findings presented in a 2006 CNN story, the flu and other infectious disease outbreaks cost the nation’s employers about $10 billion a year.

That’s why the University of Cincinnati’s Midwest Center for Emerging Infectious Diseases (MI-CEID) exists. The center serves as a touchstone for advanced medical breakthroughs to provide protection and preparedness for biological events throughout the country — including bioterrorism, biological threats, pandemic outbreaks and even seasonal flu viruses.

“The best way to head off potential public health disasters is to have a targeted means to prevent, quickly diagnose, contain and treat infections. This can only be possible through diligent and comprehensive interdisciplinary research,” said Malak Kotb, Ph.D., chair of the department of molecular genetics, biochemistry and microbiology at the University of Cincinnati College of Medicine, and senior career research scientist at the VA Medical Center.

The MI-CEID is a unique model for collaboration across diversified medical disciplines, including:

• UC Academic Health Center;
• Local hospitals including the Cincinnati Children’s Hospital Medical Center;
• Environmental Protection Agency (EPA);
• VA Medical Center;
• Regional health department;
• Public safety agencies;
• Community leaders;
• Professional associations.

“Solutions to disease treatment and prevention require innovation — and you can’t be innovative and be in silos. We achieve the best outcomes by utilizing teams of people who are skilled in their areas of knowledge,” said Kotb. “By doing this, we create something novel and effective. We need to be ahead of the curve, and at UC we have the capabilities and technology to be able to make these strides in healthcare.”

Kotb credits the cross-disciplinary nature of UC’s research facility as key to the center’s early and continued successes. Whereas similar research centers rely on collaborators that may be spread across the country, the MI-CEID brings researchers from each of the organizations above, plus the university’s College of Medicine, under one roof for optimal communication and exchange of ideas and expertise.

To combat potential health threats, the collaborative team uses a state-of-the-art approach to identify and study different types of infectious bacteria, viruses and toxins to improve their detection. The team is also conducting research to identify genetic markers that may predict disease severity in individual patients and inform the most beneficial treatment for each based on genotypes of their DNA. 

“Once we find which genes are engaged in the disease process, we can determine how they are connected through the biological networks that influence disease,” said Kotb. “This allows us to create a roadmap that can predict responses, increase protection, reduce the severity or prevent the illness or disease altogether. This helps save time, money and lives when outbreaks occur.”

Organizations have been quick to realize the potential of the MI-CEID: the National Institutes of Health (NIH), the Department of Defense and Homeland Security, the Defense Threat Reduction Agency (DTRA) and other government agencies have tapped the center for research projects with national implications. In addition, Kotb cites the importance of private support via UC’s billion-dollar Proudly Cincinnati fundraising campaign. The center also relies on corporations that contribute to the research center’s ability to remain operational year-round and expand on its research capabilities.

But while this support can fund specific research initiatives, Kotb says that funding for truly cutting-edge research can sometimes be scarce. Financial support and partnerships are always being sought to further support research and discovery, build a stronger infrastructure, and attract high caliber scientists to effectively fight existing and emerging pathogens. These activities create jobs and boost the economy.

“Private industry is an essential ingredient to successful disease-mitigation and prevention strategies. Without private support to spur on ground-breaking research, essential studies –including those that can predict infection severity in different patients and/or can help suggest the best treatment strategies, and/or predict adverse reactions to certain drugs or vaccines can certainly save lives and reduce medical costs,” Kotb said.

There will always be another pandemic disease or public health scare, but with the UC’s MI-CEID program unique vision and collaborative model the treatments will be more timely and effective. For more information on this innovative program, visit www.uc.edu.

About the University of Cincinnati
 Ranked by the National Science Foundation among the top 20 public, urban research universities in the United States, the University of Cincinnati is the region’s largest employer, with a diverse student population of more than 39,000. UC’s faculty has distinguished themselves worldwide for their creative teaching and research, including members of the National Academy of Science, Institute of Medicine and winners of Tony, Grammy and Pulitzer Prizes. The University’s 15 Colleges set the foundation for a university dedicated to undergraduate, graduate, and professional education, experience-based learning, and research. U.S. News has described UC as one of 15 “up and coming” universities and Forbes Magazine named UC one of the world’s most beautiful campuses.

About the University of Cincinnati Foundation
The University of Cincinnati Foundation is leading Proudly Cincinnati: Tower of Strength, Rock of Truth, the University’s most ambitious campaign in history, supporting the vision for UC to become the finest urban research university in the United States. Proudly Cincinnati’s goal is to raise $1 billion by 2013. To date, approximately $696 million has been raised for scholarships, innovative teaching and groundbreaking research. For more information about the Proudly Cincinnati campaign, visit www.uc.edu/foundation.

The University of Cincinnati Foundation
University Hall, Suite 100
51 Goodman Drive
Cincinnati, OH 45219
www.ProudlyCincinnati.org
www.Twitter.com/ProudlyCincy
www.Facebook.com/ProudlyCincinnati

id=”nav_links”>

CINCINNATI, OH–(Marketwire – November 22, 2010) – Healthcare information technology solutions and services provider Technology Medical Partners (TMP), today announced that it has been awarded a Qualifying Therapeutic Discovery grant from the Federal government. The $113,000 grant was awarded as part of the Patient Protection and Affordable Care Act of 2010, which was passed by Congress to provide an immediate $1 billion boost to U.S. biomedical research and the small businesses conducting the research. Only companies with less than 250 employees were eligible for the tax credits or grants. TMP’s Clinical Quality Manager (CQM) provides real-time quality of care information allowing real-time actions and improvements to patient outcomes for caregivers.

According to the National Institute of Health’s web site, the Qualifying Therapeutic Discovery tax credit or grants are tax benefits targeted to therapeutic discovery projects that show a reasonable potential to:

• Result in new therapies to treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions
• Reduce the long-term growth of health care costs in the United States
• Significantly advance the goal of curing cancer within 30 years

“Our CQM solution was created to help improve quality of care, reduce costs of care and improve income for health care providers, including increasing pay-for-performance, value based purchasing and meaningful use incentives,” stated Dr. Sunil Rao, managing partner at TMP. “This federal grant will help enhance our product development efforts so that we can continue to grow the number of patient-centered medical homes, clinics, hospitals, physicians and nurses that can benefit by having access to our system, delivering the right data at the right time. With better, timelier data, healthcare providers can provide more accurate evidence-based medicine and CMS reporting, which will help improve quality measures, patient outcomes and enhance their eligibility for government funds through pay for performance. As we like to say, quality data improves outcomes.”

TMP’s CQM solution allows healthcare providers to abstract quality of care data from any system; provide real time reports and dashboards to anyone; and support quality analytics and process improvement anywhere; functions that are not adequately provided by most electronic health records (EHR) systems to this level of detail. TMP’s CQM solution is built on the Microsoft SharePoint portal platform and abstracts patient information from disparate departments and systems, including EHR systems. Data is automatically abstracted, captured, populated and formatted into the report forms required by the Centers for Medicaid and Medicare Services. A quality database is maintained to drive all system reports, dashboards, analytics and process alerts.

About Technology Medical Partners
TMP delivers value-added information technology solutions and services to the Healthcare Industry. We focus on the business performance and quality improvement of healthcare providers (Hospitals, Clinics and Physician Practices). We bring a comprehensive array of software solutions, platform products and implementation services together with experience and leadership in Healthcare Solutions delivery. Founded in 2004, Technology Medical Partners is an Independent Software Vendor (ISV) focused on Healthcare Quality Improvement. We build Composite Software Solutions based on several technologies such as SharePoint and other Microsoft products as a Microsoft Certified ISV. We are also a partner with InterSystems and can provide our solutions built on the Cache` or Ensemble platforms. For more information, please visit www.t-m-partners.net. 

Click here to see all recent news from this company

WEST HARTFORD, CT–(Marketwire – November 22, 2010) – BroadcastMed, Inc., an interactive broadcasting company, has been recognized by the 2010 eHealthcare Leadership® Awards for its ORLive.com broadcasting portal, as a top overall internet site. The ORLive.com site was acknowledged along with The Cleveland Clinic and Mt. Sinai Medical Center. “We are extremely grateful and appreciative to be named a leading internet site by our peers in the health community,” said Ross Joel, CEO and Co-founder. Winners were recognized during a special presentation at the Fourteenth Annual Healthcare Internet Conference held November 15-17, 2010 in Las Vegas. 

Nearly 1,300 entries were received from a wide range of healthcare organizations. Factors considered in selecting the best overall internet site included delivery of strong health content, interactivity, medical care support, as well as strength of Web design and ease of navigation. Another Gold Award was bestowed on the Virtual Brain Tumor Board (MethodistHealth.or-live.com/vbtb) which BroadcastMed has developed for the Methodist University Hospital Neuroscience Institute. The Award was presented in the category of Best Health/Healthcare Content. Additionally, BroadcastMed’s work for CMEducation Resources was also cited with 12 additional awards. “Our commitment to provide comprehensive online solutions to a global audience makes this honor a huge motivator in continuing to educate our audiences with relevant content,” added Peter Gailey, President and Co-founder.

The eHealthcare Leadership Awards program exclusively recognizes the very best Web sites of healthcare organizations, online health companies, pharmaceutical/medical equipment firms, suppliers, and business improvement initiatives. The awards highlight the Internet’s role in achieving an organization’s business objectives and recognize the hard work that has gone into creating outstanding health Web sites. A total of 123 individuals familiar with healthcare and the Internet evaluated entries. Web sites were rated based on a standard of Internet excellence and how they compare with others in their group classification. For a list of winners, see: www.strategichealthcare.com/awards/winners.php. 

About BroadcastMed, Inc.

Since 1994, BroadcastMed has been providing online video solutions to hospitals, device manufacturers, and other health-related organizations. Our audience has access to thousands of hours of surgical broadcasts through our ORLive.com portal along with medical programs in other clinical disciplines, many of which include continuing medical education (CME) credit. 

Click here to see all recent news from this company

TUSTIN, CA–(Marketwire – November 22, 2010) – November is American Diabetes Month and Integrium LLC, a Contract Research Organization (CRO) with a therapeutic focus on cardiovascular and metabolic diseases, is at the forefront of clinical research to improve diabetes treatment. Eileen McAuley, Chief Operating Officer of Integrium, explains that the company has conducted 18 clinical trials of interventions for diabetes at 557 study sites. In addition to trials targeting diabetes, Integrium has conducted more than 100 cardiovascular and renal disease trials, which have an impact on diabetes care since diabetes is a leading cause of kidney failure and more than two-thirds of people with diabetes die of heart disease or stroke.

Integrium’s dedicated team of clinical researchers specializing in diabetes has pioneered therapies to improve the quality of life for people living with diabetes. Integrium’s Director of Project Management and Field Operations, Liza Moore, heads up a team with special expertise in wound healing. She explains that diabetic foot ulcers are among the most serious complications of the disease and untreated, often result in infection and amputation. “Our experience encompasses not only drugs to help manage blood glucose, but also medical devices such as bioengineered tissue products to speed wound healing. We are interested in preventing complications and effective treatment for those that can not be prevented.”

Integrium founder Dr. David H. G. Smith observes that the diabetes epidemic is not limited to the U.S. “One of our recent diabetes trials followed subjects in India, which has the largest diabetes population in the world, as well as subjects in the United States.” With its global reach, Integrium has completed trials in North America, Central and South America, the European Union and Asia for 12 of the top 20 biopharmaceutical companies.

About Diabetes
The United States is in the throes of a diabetes epidemic. An estimated 24 million children and adults have diabetes. Another 57 million others have pre-diabetes, elevated blood glucose levels that increase their risk of developing diabetes, heart disease and stroke.

One in ten American adults has diabetes and the Centers for Disease Control and Prevention (CDC) say that number could triple in the coming decades. The disease is the seventh leading cause of death in the U.S. and it is likely to be underreported as a cause of death.

Diabetes is a leading cause of kidney failure, blindness, amputations and pregnancy complications. Tighter blood glucose control reduces the symptoms and life-threatening complications of diabetes.

About Integrium, LLC
Integrium is a full-service clinical research organization (CRO) designing, conducting, and analyzing clinical trials for pharmaceutical research in dermatology, cardiovascular and metabolic disorders. It is committed to focused, specialized and long-term personalized service to its partners. It has a strong reputation for delivering high-quality management of clinical development programs. Combining the Integrium Clinical Excellence (ICE) study start-up and management methodology and therapeutic expertise leads sponsors to more confident, better-informed drug and device development decisions. For more information please visit www.integrium.com.

LANHAM, MD–(Marketwire – November 22, 2010) – The Residence on Greenbelt (www.theresidenceongreenbelt.com) will be filled with the holiday spirit when it opens its doors for the 1^st Annual Open House and Holiday Shoppe scheduled for Wednesday, December 15, 2010 from 11:00 am – 7:00 pm. The event will feature a variety of quality vendors including handcrafted items, jewelry, food products and more. A bake sale with delicious treats made by the residents will add to the festivities and enjoyment of the event. Hot apple cider, coffee and cookies for all who attend.

Event:
Open House and Holiday Shoppe

Date:
Wednesday, December 15, 2010

Location:
The Residence on Greenbelt
9885 Greenbelt Road, Lanham, MD 20706

Time:
11:00 am – 7:00 pm

Cost:
Free and open to the public

Activities:
More than a dozen vendor booths, bake sale, free treats and property tours

More Info:
Visit www.theresidenceongreenbelt.com or call (301) 486-1590

In conjunction with the Holiday Shoppe, The Residence on Greenbelt is hosting an Open House with guided tours of the property to learn more about living in a modern assisted living community. See first-hand how the community offers charm, extensive care and superior care, while allowing residents to experience its modern set of amenities including a Skype lounge and stately movie theatre equipped for the hearing impaired. Conveniently located on Greenbelt Road, The Residence on Greenbelt has recently undergone a complete renovation that has created a vibrant and interesting senior living residence, where residents can experience unrivaled service in modern and fun surroundings.

Four different service programs exist at The Residence on Greenbelt, providing the right match for the needs of seniors. In addition to Independent and Assisted Living, the community offers a Special Needs living area that provides for residents with higher acuity and mobility needs in an environment with features focused on maximizing independence while offering comfort and service. The Residence on Greenbelt also provides a unique memory care program through the Pathways Memory Care Program, an exceptional option for seniors with memory impairments as it offers a stimulating and engaging environment for residents created by each resident’s individual life story and peace of mind for their families and friends.

For more information about the Open House and Holiday Shoppe please visit www.theresidenceongreenbelt.com or call (301) 486-1590 or follow us on Facebook. For information about move-in opportunities or to set-up a private tour, please contact Patty Bay, Director of Sales and Marketing, at (866) 712-1172. The Residence on Greenbelt is located at 9885 Greenbelt Road, Lanham, MD 20706.

About IntegraCare:

IntegraCare’s mission is to “improve the quality of life for its employees, residents, and their families.” The company’s goal is to create an environment where its primary customer, the employee, experiences respect, dignity, and personal development. By providing this environment for its employees, the second half of our mission, “improve the quality life for our residents and their families,” will be achieved.

Click here to see all recent news from this company

WINNIPEG, MANITOBA–(Marketwire – Nov. 22, 2010) – DiaMedica (TSX VENTURE:DMA) today announces that in accordance with the terms of the warrant indenture for those warrants issued on June 30, 2010 the Company has provided the required written notice to holders of such warrants that the expiry date has been accelerated to the close of business December 22, 2010.

Under the terms of the indenture and the broker warrant certificates, if the 10-day volume weighted average trading price of the common shares of DiaMedica on the TSX Venture Exchange exceeds $0.75, then at any date subsequent to this date, the expiry date of the warrant shall be the day that is 30 days following the later of (i) the date that written notice of the accelerated expiry is sent to warrantholders; and (ii) the date on which the announcement of the warrant expiry acceleration is made by news release. As of the close of business on November 19, 2010, the 10-day volume-weighted average trading price of the common shares exceeded $0.75. Warrants may be exercised through payment of the exercise amount of $0.50 per full warrant up to the close of business on December 22, 2010. If all of the 6,215,000 outstanding warrants subject to this acceleration are exercised, DiaMedica will receive additional proceeds of $2.8 million. Any warrants not exercised prior to the accelerated expiry date and time will expire without any further action being taken.

About DiaMedica

DiaMedica is a biopharmaceutical company focused on developing novel treatments for type I diabetes, type 2 diabetes and other disorders. DiaMedica has completed two successful proof-of-concept II studies with DM-71 and DM-99, which demonstrate human efficacy in lowering blood glucose levels in patients with type 2 diabetes.

DiaMedica’s lead product DM-199 is a novel next generation recombinant form of DM-99, which has shown the potential to increase insulin sensitivity, reduce the autoimmune attack and trigger proliferation of pancreatic beta cells, neural stem cells and bone marrow cells. DiaMedica is listed on the TSX Venture Exchange under the trading symbol “DMA”. For further information please visit www.diamedica.com.

Caution Regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the “forward-looking statements“). These forward-looking statements relate to, among other things, DiaMedica’s objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Specifically, this press release contains forward-looking statements regarding matters such as, but not limited to, the anticipated use of proceeds from the Offering, management’s assessment of DiaMedica’s future plans, information with respect to the advancement of DiaMedica’s research and development programs, and DiaMedica’s other estimates and expectations. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to our research and development programs, the availability of additional financing, risks and uncertainties relating to the anticipated use of proceeds, changes in debt and equity markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, additional financing requirements and access to capital, unproven markets, the cost and supply of raw materials, management of growth, effects of insurers’ willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters.
Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading “Risk Factors” contained in DiaMedica’s 2009 annual information form. DiaMedica cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on DiaMedica’s forward-looking statements to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions, which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of additional financing for research and development companies, and general business and economic conditions. These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, DiaMedica cannot provide assurance that actual results will be consistent with these forward-looking statements. DiaMedica undertakes no obligation to update or revise any forward-looking statement. Additional risk factors, factors which could cause actual results to differ materially from expectations, and assumptions relating specifically to our acquisition of Sanomune may be found in our press releases dated February 18, 2010 and April 20, 2010.

RESEARCH TRIANGLE PARK, NC–(Marketwire – November 22, 2010) – The population of Brazil, Russia, India and China, roughly three billion people, coupled with these countries’ growing emphasis on strong physician-patient relationships, makes Emerging Markets a hotbed of clinical research activity, according to a new study. 

Emerging Markets Clinical Development Series: Brazil, Russia, India and China (BRIC) provides in-depth analysis on each of these countries’ benefits, advantages and challenges. The study is the latest in a series of studies from Cutting Edge Information about managing clinical trials in Emerging Markets. According to the research, patient availability is one of the top reasons driving drug companies to look to Emerging Markets for clinical trial management.

“Overall, the benefits outweigh the challenges of entering these markets,” said Jason Richardson, president of Cutting Edge Information. “Patients’ respect for their physicians’ recommendations in these markets provides clinical teams with a better chance to finish clinical testing with complete data and on time.”

A scientific advantage of the new clinical model is that much of the patient population is treatment naive, meaning that they have not already used other treatments that could change clinical results. These treatment-naive patients provide clearer effectiveness results when testing new medications. 

Emerging Markets Clinical Development Series: BRIC (http://www.cuttingedgeinfo.com/bric-clinical-trials/) provides quantitative analysis of patient availability and retention within the BRIC countries.

“For example, clinical development executives ranked India as the emerging market with the greatest patient availability, followed closely by China,” said Shaylyn Pike, senior research analyst at Cutting Edge Information. “With regard to patient retention, China, with the largest population of any country, took the top spot, followed by India.”

The new research study analyzes the potential of the BRIC markets to fulfill clinical protocols and ultimately realize significant cost and time savings. It is designed to provide clinical development teams with best practices, strategies and metrics to develop the strongest possible Emerging Markets strategies:

• Eliminate stakeholder confusion about BRIC strategy
• Master trial management in Emerging Markets
• Clarify advantages and disadvantages to boost success rates

Click here to see all recent news from this company